Moreover, the overexpression of CLU in bone-metastatic cancer cells not only apparently inhibited the invasion and migration of these bone-metastatic cancer cells, but also decreased the phosphorylation of ERK1/2 without affecting ROCK1 expression levels (Figure 6E,F). Here, ROCK1 is linked to metastatic malignant neoplasm.